4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-006336
Options or other derivatives
- President and CEO acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chacko Jacob President and CEO | 2022-02-01 | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | D | ||
| Chacko Jacob President and CEO | 2022-02-01 | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | D | ||
Loading xslF345X03/doc4.xml…